Anixa Biosciences(ANIX)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

ANIX Anixa Biosciences

盘前交易 06-05 04:59:16 EDT

2.62

+0.10

+3.97%

最高2.68	最低2.50	成交量9.24万
今开2.50	昨收2.52	日振幅7.14%
总市值8,745万	流通市值7,981万	总股本3,338万
成交额24.17万	换手率0.30%	流通股本3,046万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"ANIX","market":"US","secType":"STK","nameCN":"Anixa Biosciences","latestPrice":2.62,"timestamp":1780603200000,"preClose":2.52,"halted":0,"volume":92376,"delay":0,"changeRate":0.039682539682539715,"floatShares":30462667,"shares":33376690,"eps":-0.315087,"marketStatus":"盘前交易","change":0.1,"latestTime":"06-05 04:59:16 EDT","open":2.5,"high":2.68,"low":2.5,"amount":241681.8230712,"amplitude":0.071429,"askPrice":3.28,"askSize":100,"bidPrice":2.29,"bidSize":100,"shortable":3,"etf":0,"ttmEps":-0.315087,"tradingStatus":1,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1780666200000},"marketStatusCode":1,"adr":0,"adrRate":0,"exchange":"NASDAQ","adjPreClose":2.62,"postHourTrading":{"tag":"盘后","latestPrice":2.61,"preClose":2.62,"latestTime":"19:55 EDT","volume":500,"amount":1321.0065,"timestamp":1780617314074,"change":-0.01,"changeRate":-0.003817,"amplitude":0.01145},"volumeRatio":0.6613960796649516,"impliedVol":1.4765,"impliedVolPercentile":0.56},"requestUrl":"/m/hq/s/ANIX/tweets","defaultTab":"tweets","newsList":[{"id":"1188966229","title":"Anixa Biosciences 报告 Lira-Cel 卵巢癌 CAR-T 疗法一期试验持续呈现积极生存观察结果","url":"https://stock-news.laohu8.com/highlight/detail?id=1188966229","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1188966229?lang=zh_cn&edition=full","pubTime":"2026-05-11 20:57","pubTimestamp":1778504238,"startTime":"0","endTime":"0","summary":"Anixa Biosciences 公布了其 Lira-Cel 卵巢癌 CAR-T 疗法一期临床试验的最新数据，持续观察到积极的生存结果。这项正在进行的试验为晚期卵巢癌患者带来了新的希望。\n数据显示，接受该创新疗法的患者群体在生存期方面展现出令人鼓舞的趋势。这些更新后的观察结果进一步支持了 Lira-Cel 疗法的潜在临床价值，并为后续研究奠定了基础。\n公司将继续推进该疗法的临床开发，旨在为缺乏有效治疗选择的卵巢癌患者提供一种新的治疗途径。持续的积极数据增强了业界对该 CAR-T 细胞疗法前景的信心。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ANIX","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1140785473","title":"Anixa Biosciences 公司：前三个剂量组中未观察到剂量限制性毒性、ICANS或显著CRS","url":"https://stock-news.laohu8.com/highlight/detail?id=1140785473","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1140785473?lang=zh_cn&edition=full","pubTime":"2026-05-11 20:57","pubTimestamp":1778504234,"startTime":"0","endTime":"0","summary":"Anixa Biosciences公司宣布，在其正在进行的临床试验中，前三个剂量组均未观察到剂量限制性毒性、免疫效应细胞相关神经毒性综合征或显著的细胞因子释放综合征。这一初步安全数据为后续更高剂量的探索提供了积极信号。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","ANIX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1136800226","title":"Anixa Biosciences乳腺癌疫苗一期结果积极，推进至二期临床试验；Cytovance获选负责cGMP生产","url":"https://stock-news.laohu8.com/highlight/detail?id=1136800226","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1136800226?lang=zh_cn&edition=full","pubTime":"2026-04-01 20:51","pubTimestamp":1775047871,"startTime":"0","endTime":"0","summary":"基于一期临床试验取得的积极成果，Anixa Biosciences（ANIX）已将其乳腺癌疫苗研发项目推进至二期临床阶段。与此同时，Cytovance生物制药公司被选定负责该疫苗的cGMP（现行药品生产质量管理规范）生产工作。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ANIX","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1191961515","title":"Anixa Biosciences一期研究达到主要终点，在最大耐受剂量下展现安全性与耐受性","url":"https://stock-news.laohu8.com/highlight/detail?id=1191961515","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1191961515?lang=zh_cn&edition=full","pubTime":"2026-04-01 20:51","pubTimestamp":1775047871,"startTime":"0","endTime":"0","summary":"Anixa Biosciences公司宣布，其一项一期临床试验已成功达成预设的主要研究终点。该试验数据表明，在最大耐受剂量下，所研究的疗法表现出良好的安全性和耐受性特征。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","ANIX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1100829234","title":"Anixa Biosciences将在妇科肿瘤学会年度女性癌症大会上公布其卵巢癌CAR-T疗法临床试验数据","url":"https://stock-news.laohu8.com/highlight/detail?id=1100829234","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1100829234?lang=zh_cn&edition=full","pubTime":"2026-03-30 21:08","pubTimestamp":1774876119,"startTime":"0","endTime":"0","summary":"Anixa Biosciences宣布，其针对卵巢癌的CAR-T疗法临床试验结果，将于妇科肿瘤学会（SGO）年度女性癌症大会上正式发布。这一重要进展凸显了公司在创新癌症免疫治疗领域的持续探索。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ANIX","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1129098022","title":"Anixa Biosciences将召开2026年股东年会，并发布公司更新，重点介绍近期临床与监管进展","url":"https://stock-news.laohu8.com/highlight/detail?id=1129098022","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1129098022?lang=zh_cn&edition=full","pubTime":"2026-03-02 22:11","pubTimestamp":1772460671,"startTime":"0","endTime":"0","summary":"Anixa Biosciences宣布，公司将举办2026年度股东大会。\n届时，管理层将向股东汇报公司最新动态，重点展示在临床试验和监管事务方面取得的重要进展。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ANIX","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1138765222","title":"Anixa Biosciences卵巢癌CAR-T疗法试验获积极患者生存数据，监管批准实现重大剂量递增","url":"https://stock-news.laohu8.com/highlight/detail?id=1138765222","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1138765222?lang=zh_cn&edition=full","pubTime":"2026-02-09 21:03","pubTimestamp":1770642237,"startTime":"0","endTime":"0","summary":"Anixa Biosciences宣布，其针对卵巢癌的CAR-T细胞疗法临床试验取得鼓舞人心的患者生存观察结果。公司同时获得监管机构批准，得以实施重大剂量递增方案，为后续疗效评估提供关键支持。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ANIX","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1147079761","title":"Anixa Biosciences 获得美国采纳名称委员会对其CAR-T疗法非专利名称的批准，迈出未来商业化关键一步","url":"https://stock-news.laohu8.com/highlight/detail?id=1147079761","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1147079761?lang=zh_cn&edition=full","pubTime":"2026-02-02 22:07","pubTimestamp":1770041233,"startTime":"0","endTime":"0","summary":"Anixa Biosciences宣布，其CAR-T疗法已获得美国采纳名称委员会对非专利名称的批准。CAR-T疗法作为一种创新的癌症治疗方法，通过改造患者自身的T细胞来靶向并摧毁癌细胞，近年来在肿瘤治疗领域展现出巨大潜力。此次非专利名称的获批，不仅为Anixa Biosciences后续的临床试验、专利申请以及市场推广奠定了基础，也进一步增强了投资者对公司研发管线进展的信心。公司表示，将继续推进该疗法的临床开发工作，并积极筹备后续的商业化战略。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","ANIX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1131018543","title":"Anixa Biosciences公布研究性乳腺癌疫苗积极的第一阶段数据；主要终点已达成，74%的参与者观察到免疫反应","url":"https://stock-news.laohu8.com/highlight/detail?id=1131018543","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1131018543?lang=zh_cn&edition=full","pubTime":"2025-12-12 07:03","pubTimestamp":1765494239,"startTime":"0","endTime":"0","summary":"Anixa Biosciences公布了其研究性乳腺癌疫苗的第一阶段积极数据；所有主要终点均已达成，并且在74%的参与者中观察到免疫反应。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","ANIX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2518559277","title":"Anixa Biosciences, Inc.盘中异动 股价大跌5.63%报2.68美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2518559277","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2518559277?lang=zh_cn&edition=full","pubTime":"2025-03-10 23:45","pubTimestamp":1741621555,"startTime":"0","endTime":"0","summary":"北京时间2025年03月10日23时45分，Anixa Biosciences, Inc.股票出现波动，股价大幅下跌5.63%。Anixa Biosciences, Inc.股票所在的生物技术行业中，整体涨幅为0.16%。其相关个股中，Aeon Biopharma, Inc.、Mineralys Therapeutics, Inc.、Checkpoint Therapeutics, Inc.涨幅较大，Biodexa Pharmaceuticals Plc、Aeon Biopharma, Inc.、Scisparc Ltd.较为活跃，换手率分别为3641.67%、2398.05%、826.28%，振幅较大的相关个股有Aeon Biopharma, Inc.、Scisparc Ltd.、Dogwood Therapeutics, Inc.，振幅分别为78.32%、49.87%、41.36%。Anixa Biosciences, Inc.公司简介：Anixa Biosciences Inc 是一家专注于癌症的生物技术公司，开发疫苗和疗法，专注于肿瘤领域未满足的关键需求。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202503102345569640533d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202503102345569640533d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ANIX","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2517985225","title":"Anixa Biosciences, Inc.盘中异动 股价大涨5.28%报2.99美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2517985225","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2517985225?lang=zh_cn&edition=full","pubTime":"2025-03-05 04:29","pubTimestamp":1741120197,"startTime":"0","endTime":"0","summary":"北京时间2025年03月05日04时29分，Anixa Biosciences, Inc.股票出现波动，股价急速上涨5.28%。Anixa Biosciences, Inc.股票所在的生物技术行业中，整体涨幅为0.24%。Anixa Biosciences, Inc.公司简介：Anixa Biosciences Inc 是一家专注于癌症的生物技术公司，开发疫苗和疗法，专注于肿瘤领域未满足的关键需求。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250305042957abe854b5&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250305042957abe854b5&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ANIX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2513727017","title":"Anixa Biosciences, Inc.盘中异动 早盘急速跳水5.19%报2.92美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2513727017","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2513727017?lang=zh_cn&edition=full","pubTime":"2025-02-24 23:01","pubTimestamp":1740409260,"startTime":"0","endTime":"0","summary":"北京时间2025年02月24日23时01分，Anixa Biosciences, Inc.股票出现异动，股价大幅下挫5.19%。Anixa Biosciences, Inc.股票所在的生物技术行业中，整体涨幅为0.28%。其相关个股中，Pepgen Inc.、Estrella Immunopharma Inc C/Wts 29/09/2028、Telix Pharmaceutic涨幅较大，Pepgen Inc.、Aditxt, Inc.、Biodexa Pharmaceuticals Plc较为活跃，换手率分别为153.98%、68.47%、25.12%，振幅较大的相关个股有Pepgen Inc.、Telix Pharmaceutic、Aspire Biopharma Holdings Inc C/Wts 14/02/2030 ，振幅分别为137.23%、55.69%、41.14%。Anixa Biosciences, Inc.公司简介：Anixa Biosciences Inc 是一家专注于癌症的生物技术公司，开发疫苗和疗法，专注于肿瘤领域未满足的关键需求。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250224230100962ea038&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250224230100962ea038&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ANIX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2512431796","title":"Anixa Biosciences, Inc.盘中异动 大幅下挫5.20%","url":"https://stock-news.laohu8.com/highlight/detail?id=2512431796","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2512431796?lang=zh_cn&edition=full","pubTime":"2025-02-20 05:00","pubTimestamp":1739998850,"startTime":"0","endTime":"0","summary":"北京时间2025年02月20日05时00分，Anixa Biosciences, Inc.股票出现异动，股价大幅跳水5.20%。Anixa Biosciences, Inc.股票所在的生物技术行业中，整体涨幅为0.89%。其相关个股中，Editas Medicine, Inc.、Osr Holdings, Inc.、Osr Holdings Inc C/Wts 02/09/2028 涨幅较大，Aditxt, Inc.、Alzamend Neuro, Inc.、Osr Holdings, Inc.较为活跃，换手率分别为721.67%、261.95%、236.99%，振幅较大的相关个股有Osr Holdings Inc C/Wts 02/09/2028 、Surrozen Inc C/Wts 01/08/2031 、Osr Holdings, Inc.，振幅分别为288.38%、280.70%、160.77%。Anixa Biosciences, Inc.公司简介：Anixa Biosciences Inc 是一家专注于癌症的生物技术公司，开发疫苗和疗法，专注于肿瘤领域未满足的关键需求。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025022005005196290acb&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025022005005196290acb&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ANIX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2509420118","title":"Anixa Biosciences, Inc.盘中异动 大幅上涨5.33%","url":"https://stock-news.laohu8.com/highlight/detail?id=2509420118","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2509420118?lang=zh_cn&edition=full","pubTime":"2025-02-07 01:18","pubTimestamp":1738862309,"startTime":"0","endTime":"0","summary":"北京时间2025年02月07日01时18分，Anixa Biosciences, Inc.股票出现异动，股价急速上涨5.33%。Anixa Biosciences, Inc.股票所在的生物技术行业中，整体跌幅为0.25%。其相关个股中，Lipella Pharmaceuticals Inc.、Palatin Technologies, Inc.、Geovax Labs Inc C/Wts 29/09/2025涨幅较大，Lipella Pharmaceuticals Inc.、Transcode Therapeutics, Inc.、Azitra Inc较为活跃，换手率分别为6103.93%、1623.39%、162.97%，振幅较大的相关个股有Lipella Pharmaceuticals Inc.、Palatin Technologies, Inc.、Lakeshore Biopharma Co Ltd C/Wts 15/03/2028 ，振幅分别为125.58%、58.37%、53.02%。Anixa Biosciences, Inc.公司简介：Anixa Biosciences Inc 是一家专注于癌症的生物技术公司，开发疫苗和疗法，专注于肿瘤领域未满足的关键需求。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250207011829abc4f666&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250207011829abc4f666&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ANIX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2508493511","title":"Anixa Biosciences, Inc.盘中异动 早盘股价大跌5.69%报2.74美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2508493511","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2508493511?lang=zh_cn&edition=full","pubTime":"2025-02-03 22:38","pubTimestamp":1738593503,"startTime":"0","endTime":"0","summary":"北京时间2025年02月03日22时38分，Anixa Biosciences, Inc.股票出现波动，股价快速下挫5.69%。截至发稿，该股报2.74美元/股，成交量1.4818万股，换手率0.05%，振幅0.00%。Anixa Biosciences, Inc.股票所在的生物技术行业中，整体跌幅为0.39%。Anixa Biosciences, Inc.公司简介：Anixa Biosciences Inc 是一家专注于癌症的生物技术公司，开发疫苗和疗法，专注于肿瘤领域未满足的关键需求。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250203223824abc108c7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250203223824abc108c7&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ANIX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2507548810","title":"Anixa Biosciences, Inc.盘中异动 早盘股价大涨6.92%","url":"https://stock-news.laohu8.com/highlight/detail?id=2507548810","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2507548810?lang=zh_cn&edition=full","pubTime":"2025-01-28 22:34","pubTimestamp":1738074872,"startTime":"0","endTime":"0","summary":"北京时间2025年01月28日22时34分，Anixa Biosciences, Inc.股票出现波动，股价大幅上涨6.92%。Anixa Biosciences, Inc.股票所在的生物技术行业中，整体涨幅为0.07%。其相关个股中，Lakeshore Biopharma Co Ltd C/Wts 15/03/2028 、Silexion Therapeutics Corp C/Wts Exp 15/08/2029 、Hepion Pharmaceuticals, Inc.涨幅较大，Hepion Pharmaceuticals, Inc.、Conduit Pharmaceuticals Inc.、Nls Pharmaceutics Ltd.较为活跃，换手率分别为701.42%、222.83%、151.36%，振幅较大的相关个股有Tonix Pharmaceuticals Holding Corp.、Allarity Therapeutics, Inc.、Zymeworks Inc.，振幅分别为113.08%、103.25%、101.04%。Anixa Biosciences, Inc.公司简介：Anixa Biosciences Inc 是一家专注于癌症的生物技术公司，开发疫苗和疗法，专注于肿瘤领域未满足的关键需求。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250128223433abbb666f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250128223433abbb666f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ANIX","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2505590862","title":"Anixa Biosciences, Inc.盘中异动 早盘股价大跌5.48%","url":"https://stock-news.laohu8.com/highlight/detail?id=2505590862","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2505590862?lang=zh_cn&edition=full","pubTime":"2025-01-24 23:38","pubTimestamp":1737733094,"startTime":"0","endTime":"0","summary":"北京时间2025年01月24日23时38分，Anixa Biosciences, Inc.股票出现异动，股价快速下挫5.48%。Anixa Biosciences, Inc.股票所在的生物技术行业中，整体跌幅为0.45%。其相关个股中，Evaxion Biotech As、Pmgc Holdings Inc.、Transcode Therapeutics, Inc.涨幅较大，Evaxion Biotech As、Pmgc Holdings Inc.、Transcode Therapeutics, Inc.较为活跃，换手率分别为3558.88%、1861.71%、1358.91%，振幅较大的相关个股有Psyence Biomedical Ltd C/Wts 25/01/2029、Evaxion Biotech As、Windtree Therapeutics, Inc.，振幅分别为134.08%、112.09%、66.25%。Anixa Biosciences, Inc.公司简介：Anixa Biosciences Inc 是一家专注于癌症的生物技术公司，开发疫苗和疗法，专注于肿瘤领域未满足的关键需求。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250124233815a22e6999&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250124233815a22e6999&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ANIX","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2505279012","title":"Anixa Biosciences, Inc.盘中异动 股价大涨7.88%报2.60美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2505279012","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2505279012?lang=zh_cn&edition=full","pubTime":"2025-01-21 22:33","pubTimestamp":1737469988,"startTime":"0","endTime":"0","summary":"北京时间2025年01月21日22时33分，Anixa Biosciences, Inc.股票出现异动，股价大幅拉升7.88%。截至发稿，该股报2.60美元/股，成交量4.3716万股，换手率0.14%，振幅1.04%。Anixa Biosciences, Inc.股票所在的生物技术行业中，整体涨幅为0.89%。Anixa Biosciences, Inc.公司简介：Anixa Biosciences Inc 是一家专注于癌症的生物技术公司，开发疫苗和疗法，专注于肿瘤领域未满足的关键需求。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250121223308abb34708&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250121223308abb34708&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ANIX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2504197539","title":"Anixa Biosciences, Inc.盘中异动 急速下挫5.04%","url":"https://stock-news.laohu8.com/highlight/detail?id=2504197539","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2504197539?lang=zh_cn&edition=full","pubTime":"2025-01-18 01:49","pubTimestamp":1737136140,"startTime":"0","endTime":"0","summary":"北京时间2025年01月18日01时49分，Anixa Biosciences, Inc.股票出现异动，股价快速跳水5.04%。Anixa Biosciences, Inc.股票所在的生物技术行业中，整体涨幅为0.75%。Anixa Biosciences, Inc.公司简介：Anixa Biosciences Inc 是一家专注于癌症的生物技术公司，致力于开发那些肿瘤学中未满足的关键需求的疫苗和疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250118014900abaedc33&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250118014900abaedc33&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ANIX","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2503916193","title":"Anixa Biosciences, Inc.盘中异动 早盘股价大涨5.09%","url":"https://stock-news.laohu8.com/highlight/detail?id=2503916193","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2503916193?lang=zh_cn&edition=full","pubTime":"2025-01-16 23:11","pubTimestamp":1737040269,"startTime":"0","endTime":"0","summary":"北京时间2025年01月16日23时11分，Anixa Biosciences, Inc.股票出现异动，股价大幅上涨5.09%。Anixa Biosciences, Inc.股票所在的生物技术行业中，整体跌幅为0.90%。Anixa Biosciences, Inc.公司简介：Anixa Biosciences Inc 是一家专注于癌症的生物技术公司，致力于开发那些肿瘤学中未满足的关键需求的疫苗和疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250116231110960610f9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250116231110960610f9&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ANIX","BK4139"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.anixa.com","stockEarnings":[{"period":"1week","weight":-0.0296},{"period":"1month","weight":-0.1267},{"period":"3month","weight":-0.0807},{"period":"6month","weight":-0.453},{"period":"1year","weight":-0.0609},{"period":"ytd","weight":-0.1603}],"compareEarnings":[{"period":"1week","weight":0.0033},{"period":"1month","weight":0.046},{"period":"3month","weight":0.126},{"period":"6month","weight":0.1041},{"period":"1year","weight":0.2704},{"period":"ytd","weight":0.1102}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Anixa Biosciences, Inc.根据特拉华州法律于1982年11月5日注册成立，是一家生物技术公司，致力于开发针对肿瘤和传染病的关键未满足需求的疗法和疫苗。公司的主要业务是开发嵌合内分泌受体T细胞技术以及发现和最终开发抗癌药物-用于治疗COVID-19的病毒候选药物集中于抑制病毒的某些病毒蛋白功能。","yearOnYearQuotes":[{"month":1,"riseRate":0.727273,"avgChangeRate":0.14227},{"month":2,"riseRate":0.272727,"avgChangeRate":-0.055581},{"month":3,"riseRate":0.181818,"avgChangeRate":-0.072942},{"month":4,"riseRate":0.363636,"avgChangeRate":-0.00589},{"month":5,"riseRate":0.363636,"avgChangeRate":-0.087307},{"month":6,"riseRate":0.363636,"avgChangeRate":0.040993},{"month":7,"riseRate":0.7,"avgChangeRate":0.091843},{"month":8,"riseRate":0.545455,"avgChangeRate":0.006342},{"month":9,"riseRate":0.636364,"avgChangeRate":0.312097},{"month":10,"riseRate":0.363636,"avgChangeRate":0.031849},{"month":11,"riseRate":0.363636,"avgChangeRate":-0.010369},{"month":12,"riseRate":0.363636,"avgChangeRate":-0.073586}],"exchange":"NASDAQ","name":"Anixa Biosciences","nameEN":"Anixa Biosciences"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.43.1","shortVersion":"4.43.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Anixa Biosciences(ANIX)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Anixa Biosciences(ANIX)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Anixa Biosciences,ANIX,Anixa Biosciences股票,Anixa Biosciences股票老虎,Anixa Biosciences股票老虎国际,Anixa Biosciences行情,Anixa Biosciences股票行情,Anixa Biosciences股价,Anixa Biosciences股市,Anixa Biosciences股票价格,Anixa Biosciences股票交易,Anixa Biosciences股票购买,Anixa Biosciences股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Anixa Biosciences(ANIX)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Anixa Biosciences(ANIX)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}